Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Peptides ; 21(9): 1427-32, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11072131

RESUMEN

Glucose-dependent insulinotropic peptide (GIP) potentiates glucose-induced insulin secretion. In addition, GIP has vasoconstrictive or vasodilatory properties depending on the vascular bed affected. In order to assess whether this effect could be related to differences in GIP receptor expression, several different endothelial cell types were examined for GIP receptor expression. GIP receptor splice variants were detected and varied depending on the endothelial cell type. Furthermore, stimulation of these cells with GIP led to cell type dependent differences in activation of the calcium and cAMP signaling pathways. To our knowledge this is the first physiological characterization of receptors for GIP in endothelial cells.


Asunto(s)
Señalización del Calcio , Endotelio Vascular/fisiología , Polipéptido Inhibidor Gástrico/metabolismo , Fragmentos de Péptidos/metabolismo , Receptores de la Hormona Gastrointestinal/aislamiento & purificación , Empalme Alternativo , Aorta/citología , Circulación Sanguínea , Calcio/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Humanos , Arteria Pulmonar/citología , ARN Mensajero/aislamiento & purificación , Receptores de la Hormona Gastrointestinal/genética , Distribución Tisular , Venas Umbilicales/citología
2.
Am J Physiol Endocrinol Metab ; 279(3): E654-62, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10950835

RESUMEN

Acute parathyroid hormone exposure induces vascular smooth muscle relaxation. In contrast, continuous infusion of parathyroid hormone leads to vasoconstriction and an elevation of blood pressure. Despite the known effects of parathyroid hormone on vascular smooth muscle, possible direct effects on the vascular endothelium have not previously been investigated. Using a human umbilical vein endothelial cell line, we found that parathyroid hormone increased both intracellular calcium and cellular cAMP content in these endothelial cells. Furthermore, exposure of these cells to increasing concentrations of parathyroid hormone stimulated both [(3)H]thymidine incorporation and endothelin-1 secretion. Parathyroid hormone/parathyroid hormone-related peptide receptor mRNA could be detected at low levels in these cells. In summary, these data demonstrate that endothelium-derived cells contain functional parathyroid hormone receptors. The potential physiological role of these receptors remains to be determined.


Asunto(s)
Endotelio Vascular/metabolismo , Receptores de Hormona Paratiroidea/metabolismo , Venas Umbilicales/metabolismo , Calcio/metabolismo , Línea Celular , Cromatografía Líquida de Alta Presión , AMP Cíclico/biosíntesis , Endotelina-1/metabolismo , Endotelio Vascular/citología , Colorantes Fluorescentes , Fura-2 , Gliceraldehído-3-Fosfato Deshidrogenasas/metabolismo , Humanos , Fosfatos de Inositol/metabolismo , Hormona Paratiroidea/metabolismo , ARN Mensajero/biosíntesis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/fisiología , Timidina/metabolismo , Venas Umbilicales/citología
3.
Biochem Biophys Res Commun ; 231(1): 156-9, 1997 Feb 03.
Artículo en Inglés | MEDLINE | ID: mdl-9070240

RESUMEN

Previous studies showed that insulin stimulation of electrogenic Na+ transport in renal epithelial cells is mediated by a calcium-dependent signal transduction mechanism. The present study was performed to determine whether the insulin-induced increase in intracellular Ca2+ (Cai2+) was mediated by hydrolysis of phosphatidylinositol and release of inositol trisphosphate. Experiments were conducted with cultured A6 cells, derived from Xenopus Laevis, grown on permeable supports. Addition of insulin resulted in 2 to 3 fold increases in inositol trisphosphate and a 50% increase in 1,2 diacylglycerol within 10s, which corresponded to the time-course, previously reported, of insulin stimulated increases in Na+ transport and Cai2+. Further studies showed that aldosterone, previously shown to stimulate an increase in 1,4,5-inositol trisphosphate at onset of the rise in Na+ transport, also increased DAG levels during the initial phase of stimulation of Na+ transport. These studies provide the first evidence that a biological response induced by insulin is mediated by hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) which results in two products, inositol trisphosphate which causes the release of Ca2+ from intracellular stores and 1,2 diacylglycerol. In addition this study provides further support for the proposal that a common signal transduction mechanism mediates electrogenic Na+ transport by multiple agonists.


Asunto(s)
Fosfatos de Inositol/metabolismo , Insulina/farmacología , Fosfatidilinositol 4,5-Difosfato/metabolismo , Sodio/metabolismo , Aldosterona/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Calcio/metabolismo , Células Clonales , Diglicéridos/metabolismo , Transducción de Señal , Xenopus laevis
4.
Endocrinology ; 137(12): 5376-85, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8940360

RESUMEN

A midregion fragment of PTH-related protein (PTHrP), which is intensively conserved across species, has been identified as a secretory product of several different cell types, including keratinocytes and squamous carcinomas. As recent data suggest that a midregion PTHrP fragment may be biologically active, we hypothesized that midregion PTHrPs interact with unique cell surface receptors that mediate autocrine or paracrine action. Dose-dependent transient elevations in intracellular calcium ([Ca2-]i) were observed in fura-2-loaded SqCC/Y1 squamous carcinoma cells exposed to human (h) PTHrP-(67-86)NH2, [Tyr36]hPTHrP-(1-36)NH2, and hPTHrP-(1-141) at concentrations ranging from 1 pM to 1 microM. The effects of maximal stimulatory concentrations of [Tyr36]PTHrP-(1-36)NH2 and PTHrP-(67-86)NH2 on [Ca2+]i were additive. The inhibitory PTH analog, [D-Trp12,Tyr34]bovine PTH-(7-34)NH2, attenuated the [Ca2+]i response to [Tyr36]hPTHrP-(1-36)NH2, but not that to PTHrP-(67-86)NH2. These data suggest that PTHrP-(67-86)NH2 activates a different receptor pathway in SqCC/Y1 cells from the one activated by [Tyr36]hPTHrP-(1-36)NH2. Radiolabeled PTHrP-(67-86)NH2 did not bind to SqCC/Y1 cells, and PTHrP-(67-86)NH2 did not compete for binding of 125I-labeled [Tyr36]PTHrP-(1-36)NH2 to PTH/PTHrP receptors on SaOS-2 osteosarcoma cells. Activation of the phospholipase C pathway by PTHrP-(67-86)NH2 was confirmed by exposing SqCC/Y1 cells to peptide for 1 min and measuring the accumulation of inositol trisphosphates. PTHrP-(67-86)NH2 treatment (100 nM) resulted in maximal stimulation of inositol trisphosphates of 3.1 +/- 0.1-fold over the control value, with an EC50 of 1.5 +/- 1.2 nm. In contrast, PTHrP-(67-86)NH2 (0.1 nM to 1 microM) did not stimulate adenylyl cyclase in SqCC/Y1 cells despite vigorous stimulation of cAMP formation by isoproterenol (1 microM) to 66-fold over the basal value. To determine whether messenger RNA (mRNA) prepared from SqCC/Y1 cells would direct the translation of a receptor protein that mediated a [Ca2+]i response to PTHrP-(67-86)NH2, we performed expression studies in Xenopus oocytes. Fluo-3 fluorescence in Xenopus oocytes expressing SqCC/Y1 mRNA was visualized by confocal video microscopy after exposure to 1 microM PTHrP-(67-86)NH2. Clear increases in [Ca2+]i were detected in mRNA-injected, but not in sham-injected, oocytes. Finally, we examined the effect of PTHrP-(67-86)NH2 treatment on fibronectin secretion from SqCC/YN1 cells. A significant 3.5-fold increase in fibronectin secretion into conditioned medium was observed when SqCC/Y1 cells were exposed to 100 nM PTHrP-(67-86)NH2, and this effect was dose dependent, with an EC50 of 0.1 nM. We conclude that PTHrP-(67-86)NH2 activates phospholipase C-dependent pathways in SqCC/Y1 cells through a receptor distinct from that activated by PTHrP-(1-36) in the same cells. As a midregion secretory fragment of PTHrP has been partially purified from several different cell types, this receptor may have broad biological significance.


Asunto(s)
Calcio/metabolismo , Carcinoma de Células Escamosas/metabolismo , Citosol/metabolismo , Inositol 1,4,5-Trifosfato/biosíntesis , Fragmentos de Péptidos/farmacología , Proteínas/farmacología , Animales , Transporte Biológico/efectos de los fármacos , Carcinoma de Células Escamosas/patología , AMP Cíclico/metabolismo , Fibronectinas/metabolismo , Humanos , Oocitos/metabolismo , Proteína Relacionada con la Hormona Paratiroidea , Fosfatidilinositoles/metabolismo , Receptor de Hormona Paratiroídea Tipo 1 , Receptores de Hormona Paratiroidea/metabolismo , Células Tumorales Cultivadas , Xenopus
6.
Biochem Biophys Res Commun ; 214(2): 373-88, 1995 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-7677744

RESUMEN

The most commonly used calcium-sensitive probes for the measurement of [Ca2+]i are fluorescent probes such as fura-2 or luminescent probes like aequorin. There are inherent theoretical limitations and benefits associated with the use of either probe in the measurement of cytosolic calcium. Using a cultured human umbilical endothelial cell line, we have investigated the role of the buffer used, the pH and the magnesium concentration on [Ca2+]i measurements, as well as fura-2 loading conditions, using both fura-2 and aequorin. We report that the use of non-physiological buffers (HEPES) can lead to an elevation of [Ca2+]i whether measured with fura-2 or aequorin. In addition, using buffers with low magnesium concentrations (< 1 mM) or alkaline pH0 can result in an apparent elevation in the [Ca2+]i during the sustained phase of the cellular response. Taken together these data suggest that similar results in the measurements of intracellular calcium can be obtained irrespective of the probe utilized. In addition, our data demonstrate that the conditions for cellular studies must be selected with care, since numerous artefacts can be introduced into measurements of intracellular calcium by the use of non-physiological conditions.


Asunto(s)
Aequorina , Calcio/metabolismo , Endotelio Vascular/metabolismo , Fluoresceínas , Colorantes Fluorescentes , Fura-2 , Tampones (Química) , Calcio/análisis , Células Cultivadas , Citosol/efectos de los fármacos , Citosol/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Cinética , Magnesio/farmacología , Factores de Tiempo , Venas Umbilicales
7.
Biochem Biophys Res Commun ; 213(2): 688-98, 1995 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-7646525

RESUMEN

The effects of parathyroid hormone (PTH) on sodium homeostasis in the distal tubule are not well defined. Using A6 cells as a model for distal tubular epithelium we measured equivalent short circuit current (leq), as an estimate of net sodium transport. We found that PTH increased leq in a dose-dependent manner. DDA, an agent which inhibits adenylate cyclase, decreased PTH-activated sodium transport, suggesting a role for cAMP elevation in PTH effects. Moreover, addition of Rp-cAMP, an inhibitor of cAMP-dependent protein kinase, partially blocked the PTH-stimulated leq. PTH also elicited a sustained increase in [Ca2+]i in A6 cells. This elevation in [Ca2+]i was abolished by removal of calcium from the extracellular medium, suggesting the involvement of calcium influx pathways. In fact, addition of the calcium channel blocker nitrendipine to PTH-stimulated leq partially blocked PTH-activated sodium transport. Taken together these data demonstrate that PTH stimulates electrogenic sodium transport in A6 cells and that this effect may be mediated through a rise in both intracellular calcium and cellular cAMP.


Asunto(s)
Riñón/metabolismo , Hormona Paratiroidea/farmacología , Sodio/metabolismo , Inhibidores de Adenilato Ciclasa , Animales , Transporte Biológico/efectos de los fármacos , Calcimicina/farmacología , Calcio/metabolismo , Línea Celular , Colforsina/farmacología , AMP Cíclico/metabolismo , Citosol/metabolismo , Didesoxiadenosina/farmacología , Conductividad Eléctrica , Epitelio/efectos de los fármacos , Epitelio/metabolismo , Riñón/efectos de los fármacos , Nitrendipino/farmacología , Transducción de Señal , Xenopus laevis
8.
Kidney Int ; 47(6): 1576-84, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7643526

RESUMEN

Studies were performed to determine the primary signal transduction mechanism that mediates adenosine stimulation of electrogenic sodium transport in renal epithelial cells. Experiments were performed on cultured amphibian A6 cells with an adenosine analogue that preferentially binds to the A1 receptor, cyclohexyladenosine (CHA). Sodium transport was assessed by the equivalent short circuit current (Ieq). CHA was found to stimulate Ieq via activation of an A1 receptor because (1) the threshold concentration was 1 nM compared to that of 10 microM for the specific A2 agonist CGS21680, (2) CHA inhibited vasopressin (AVP)-stimulated cAMP production by a pertussis toxin-sensitive mechanism, and (3) the action of CHA was inhibited by the A1 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX). CHA increased intracellular Ca2+ ([Ca2+]i) and stimulated phosphoinositide turnover at concentrations that increased Ieq and in a time course that paralleled the increase in Ieq. Ion transport was stimulated by a Ca(2+)-dependent mechanism because the CHA induced increase in Ieq was inhibited by chelating [Ca2+]i with 5,5'dimethyl BAPTA in a dose-dependent manner, with a Ki of approximately 10 microM. The increase in Ieq was also dose-dependently inhibited by the specific PKC inhibitors dihydroxychlorpromazine and chelerythrine, and by trifluoperazine which inhibits PKC and calmodulin. Further studies indicated that CHA-stimulated Ieq was independent of cAMP generation because CHA did not induce an increase in cAMP accumulation parallel to the increase in Ieq in a dose-response analysis, and the adenylate cyclase inhibitor 2',5' dideoxy-adenosine (DDA) did not affect the CHA-induced increase in Ieq.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Adenosina/farmacología , Calcio/fisiología , Membranas Intracelulares/metabolismo , Receptores Purinérgicos P1/fisiología , Sodio/metabolismo , Adenosina/análogos & derivados , Adenilil Ciclasas/fisiología , Animales , Transporte Biológico/efectos de los fármacos , AMP Cíclico/fisiología , Electrofisiología , Concentración Osmolar , Proteínas Quinasas/fisiología , Xenopus laevis
9.
Kidney Int ; 46(3): 666-74, 1994 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7996787

RESUMEN

Studies were performed to determine the signal transduction mechanism involved in the onset of insulin stimulated electrogenic sodium transport (Ieq) in cultured A6 cells. Insulin stimulated Ieq at a threshold concentration of one nM and a half-maximum concentration of approximately 3 nM. The onset of action occurred within 10 seconds and the increase in Ieq was augmented by pretreatment with aldosterone, similar to the action of vasopressin. Insulin stimulated an increase in Ca2+i in a dose-dependent manner that involved release from intracellular stores. Hormone stimulated Ieq was dependent on increases in Ca2+i because pretreatment with 5, 5' dimethyl BAPTA/AM blocked the increase in sodium transport. Further studies with dihydroxyclorpromazine, trifluoperazine and genistein, inhibitors of PKC, Ca2+i dependent, calmodulin dependent kinases and tyrosine kinase, respectively, suggested that the action of insulin was dependent on activation of these kinases. In contrast, insulin stimulated Ieq was independent of changes in cAMP, because insulin did not increase the accumulation of cAMP, and inhibition of adenylate cyclase with 2', 5' dideoxyadenosine did not affect transport. These results suggest that insulin, as previously shown for aldosterone, activates apical membrane amiloride sensitive sodium channels by a calcium-dependent second messenger system.


Asunto(s)
Insulina/farmacología , Riñón/fisiología , Sodio/fisiología , Aldosterona/farmacología , Animales , Transporte Biológico , Calcio/metabolismo , Línea Celular , Células Cultivadas , Relación Dosis-Respuesta a Droga , Epitelio/efectos de los fármacos , Epitelio/metabolismo , Epitelio/fisiología , Riñón/efectos de los fármacos , Riñón/metabolismo , Potenciales de la Membrana , Inhibidores de Proteínas Quinasas , Transducción de Señal , Sodio/metabolismo , Canales de Sodio/efectos de los fármacos , Vasopresinas/farmacología , Xenopus laevis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA